Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Angenendt · SciRah

Researcher profile · Semantic Scholar

L. Angenendt

Share profile

L. Angenendt — researcher profile on SciRah

h-index: 16
Works: 49
Citations: 990

Most-cited papers

CD70-specific CAR T-cells have potent activity against Acute Myeloid Leukemia (AML) without HSC toxicity.
T. Sauer, Kathan Parikh, Sandhya Sharma, Bilal Omer +8 more
2021Blood149 citations Open access
Semantic Scholar
Chromosomal Abnormalities and Prognosis in NPM1-Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts.
L. Angenendt, C. Röllig, P. Montesinos, D. Martínez-Cuadrón +41 more
2019Journal of Clinical Oncology103 citations Open access
Semantic Scholar
Clonally resolved single-cell multi-omics identifies routes of cellular differentiation in acute myeloid leukemia
S. Beneyto-Calabuig, A. Merbach, J.-A. Kniffka, M. Antes +27 more
2022bioRxiv84 citations Open access
Semantic Scholar
Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML
T. Oellerich, C. Schneider, Dominique Thomas, K. Knecht +20 more
2019Nature Communications64 citations Open access
Semantic Scholar
Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells
C. Larrue, N. Guiraud, P. Mouchel, Marine Dubois +21 more
2020Nature Communications61 citations Open access
Semantic Scholar
Nivolumab in a patient with refractory Hodgkin’s lymphoma after allogeneic stem cell transplantation
L. Angenendt, C. Schliemann, M. Lutz, E. Rebber +9 more
2016Bone Marrow Transplantation54 citations
Semantic Scholar
Targeting Interleukin-2 to the Bone Marrow Stroma for Therapy of Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation
C. Schliemann, Katrin L. Gutbrodt, Andrea Kerkhoff, Michele Pohlen +15 more
2014Cancer immunology research45 citations Open access
Semantic Scholar
The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia
L. Angenendt, E. Bormann, C. Pabst, V. Alla +30 more
2019Leukemia43 citations Open access
Semantic Scholar
Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears
Jacqueline Kockwelp, Sebastian Thiele, Jannis Bartsch, Lars Haalck +11 more
2023Blood Advances34 citations Open access
Semantic Scholar
ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare Disorder
S. Pierson, J. Khor, Jasira Ziglar, Amy Y. Liu +30 more
2020Cell Reports Medicine32 citations Open access
Semantic Scholar
Low‐density lipoprotein receptor (LDLR) is an independent adverse prognostic factor in acute myeloid leukaemia
Matthias Floeth, S. Elges, J. Gerss, C. Schwöppe +9 more
2020British Journal of Haematology21 citations Open access
Semantic Scholar
Aminopeptidase N (CD13): Expression, Prognostic Impact, and Use as Therapeutic Target for Tissue Factor Induced Tumor Vascular Infarction in Soft Tissue Sarcoma
T. Kessler, Ariane Baumeier, C. Brand, M. Grau +15 more
2018Translational Oncology21 citations Open access
Semantic Scholar
NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor
C. Brand, C. Schliemann, J. Ring, T. Kessler +10 more
2016OncoTarget21 citations Open access
Semantic Scholar
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study
C. Schliemann, M. Gerwing, H. Heinzow, S. Harrach +23 more
2020Cancers20 citations Open access
Semantic Scholar
Are formalin-fixed and paraffin-embedded tissues fit for proteomic analysis?
Malte Bayer, L. Angenendt, C. Schliemann, W. Hartmann +1 more
2020Journal of Mass Spectrometry19 citations
Semantic Scholar
Revisiting Co-existing Chromosomal Abnormalities in NPM1-mutated AML in Light of the Revised ELN 2022 classification.
L. Angenendt, C. Röllig, P. Montesinos, F. Ravandi +6 more
2022Blood17 citations
Semantic Scholar
Dose escalation and expansion phase I studies with the tumour-targeting antibody-tumour necrosis factor fusion protein L19TNF plus doxorubicin in patients with advanced tumours, including sarcomas.
C. Schliemann, T. Hemmerle, A. Berdel, L. Angenendt +11 more
2021European Journal of Cancer17 citations
Semantic Scholar
RNA-Guided CRISPR-Cas9 System-Mediated Engineering of Acute Myeloid Leukemia Mutations
Oliver Brabetz, V. Alla, L. Angenendt, C. Schliemann +3 more
2017Molecular Therapy: Nucleic Acids16 citations Open access
Semantic Scholar
Calcitonin receptor‐like (CALCRL) is a marker of stemness and an independent predictor of outcome in pediatric AML
L. Angenendt, M. Wöste, J. Mikesch, M. Arteaga +8 more
2021Blood Advances15 citations Open access
Semantic Scholar
A Phase I Dose Escalation Study of the Triple Angiokinase Inhibitor Nintedanib Combined with Low-Dose Cytarabine in Elderly Patients with Acute Myeloid Leukemia
C. Schliemann, J. Gerss, S. Wiebe, J. Mikesch +11 more
2016PLoS ONE14 citations Open access
Semantic Scholar
Potentiating the activity of rituximab against mantle cell lymphoma in mice by targeting interleukin-2 to the neovasculature.
Niklas Börschel, C. Schwöppe, Caroline Zerbst, L. Angenendt +8 more
2015Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis14 citations
Semantic Scholar
Using stroma-anchoring cytokines to augment ADCC: a phase 1 trial of F16IL2 and BI 836858 for posttransplant AML relapse
A. Berdel, L. Ruhnke, L. Angenendt, M. Wermke +20 more
2022Blood Advances12 citations Open access
Semantic Scholar
AAA+ ATPases Reptin and Pontin as potential diagnostic and prognostic biomarkers in salivary gland cancer - a short report
J. Mikesch, W. Hartmann, L. Angenendt, O. Huber +7 more
2018Cellular Oncology12 citations Open access
Semantic Scholar
Characteristics and Outcome of Elderly Patients (>55 Years) with Acute Lymphoblastic Leukemia
Daniela V. Wenge, Klaus Wethmar, Corinna A. Klar, H. Kolve +15 more
2022Cancers11 citations Open access
Semantic Scholar
Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemia
Klaus Wethmar, S. Matern, Eva Esseling, L. Angenendt +12 more
2020Bone Marrow Transplantation10 citations
Semantic Scholar
Epigenetic control over the cell-intrinsic immune response antagonizes self-renewal in acute myeloid leukemia
Eloisa Felipe Fumero, C. Walter, J. Frenz, F. Seifert +16 more
2024Blood9 citations Open access
Semantic Scholar
Magnesium levels and outcome after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
L. Angenendt, Isabel Hilgefort, J. Mikesch, B. Schlüter +4 more
2020Annals of Hematology9 citations Open access
Semantic Scholar
Reptin drives tumour progression and resistance to chemotherapy in nonsmall cell lung cancer
J. Mikesch, Daniela Schwammbach, W. Hartmann, L. Schmidt +11 more
2018European Respiratory Journal9 citations Open access
Semantic Scholar
Stromal collagen type VI associates with features of malignancy and predicts poor prognosis in salivary gland cancer
L. Angenendt, J. Mikesch, D. Görlich, Alina Busch +8 more
2018Cellular Oncology8 citations Open access
Semantic Scholar
Remissions of different quality following rituximab, tocilizumab and rituximab, and allogeneic stem cell transplantation in a patient with severe idiopathic multicentric Castleman’s disease
L. Angenendt, Andrea Kerkhoff, S. Wiebe, J. Mikesch +9 more
2015Annals of Hematology8 citations
Semantic Scholar
Pretransplant spleen volume and outcome after hematopoietic stem cell transplantation (HSCT) in patients with acute myeloid leukemia (AML)
A. Pohlmann, Eva Bentgens, C. Schülke, D. Kuron +7 more
2023Annals of Hematology7 citations Open access
Semantic Scholar
Cell Selection-based Data Reduction Pipeline for Whole Slide Image Analysis of Acute Myeloid Leukemia
Jacqueline Kockwelp, S. Thiele, Pascal Kockwelp, Jannis Bartsch +3 more
20222022 IEEE/CVF Conference on Computer Vision and Pattern Recognition Workshops (CVPRW)7 citations
Semantic Scholar
Phase I study of F16IL2 antibody–cytokine fusion with very low‐dose araC in acute myeloid leukaemia relapse after allogeneic stem cell transplantation
C. Schliemann, T. Kessler, A. Berdel, T. Hemmerle +9 more
2021British Journal of Haematology7 citations Open access
Semantic Scholar
Amsacrine-based induction therapy in AML patients with cardiac comorbidities: a retrospective single-center analysis
D. Kuron, A. Pohlmann, L. Angenendt, T. Kessler +6 more
2023Annals of Hematology6 citations Open access
Semantic Scholar
Emerging antibody-based therapies for the treatment of acute myeloid leukemia.
L. Angenendt, J. Mikesch, C. Schliemann
2022Cancer Treatment Reviews6 citations
Semantic Scholar
A Phase I Trial of the Antibody-Cytokine Fusion Protein F16IL2 in Combination with Anti-CD33 Immunotherapy for Posttransplant AML Relapse
A. Berdel, C. Rollig, M. Wermke, L. Angenendt +17 more
2021Blood4 citations Open access
Semantic Scholar
A randomized phase 2 trial of nintedanib and low-dose cytarabine in elderly patients with acute myeloid leukemia ineligible for intensive chemotherapy
A. Berdel, R. Koch, J. Gerss, M. Hentrich +14 more
2022Annals of Hematology3 citations Open access
Semantic Scholar
A case of idiopathic multicentric Castleman disease in an alemtuzumab-treated patient with MS
L. Rolfes, S. Pfeuffer, T. Ruck, S. Windhagen +6 more
2019Neurology: Neuroimmunology & Neuroinflammation2 citations Open access
Semantic Scholar
Prevalence and clinical impact of CD56 and T‐cell marker expression in acute myeloid leukaemia: A single‐centre retrospective analysis
I. Shaforostova, S. Call, G. Evers, C. Reicherts +9 more
2023eJHaem1 citations Open access
Semantic Scholar
Pure red cell aplasia after kidney transplantation
L. Angenendt, S. Huss, C. Schliemann, S. Reuter
2019American Journal of Transplantation1 citations Open access
Semantic Scholar
Impact of European LeukemiaNet–guided postremission therapy on outcomes of patients with AML from 2010 to 2022
A. Berdel, Julian Ronnacker, Daniela V. Wenge, Lina J. Kolloch +14 more
2025Blood neoplasia0 citations Open access
Semantic Scholar
“As Treated” Validation of the European LeukemiaNet (ELN) Classification for Adult Acute Myeloid Leukemia (AML) Patients (pts) Treated in a Large AML-Referral Center from 2010-2022
A. Berdel, Julian Ronnacker, Daniela V. Wenge, Lina J. Kolloch +14 more
2024Blood0 citations
Semantic Scholar
Characteristics and Outcome of Elderly Patients (> 55 Years) with Acute Lymphoblastic Leukemia (ALL)
Daniela V. Wenge, Klaus Wethmar, Corinna A. Klar, H. Kolve +15 more
2021Blood0 citations
Semantic Scholar
563P First-in-class CD13-targeted tissue factor tTF-NGR in patients with recurrent or refractory malignant tumours: Safety and pharmacokinetic results of a phase I study
C. Schliemann, M. Gerwing, H. Heinzow, S. Harrach +16 more
20200 citations Open access
Semantic Scholar
S1614 CHROMOSOMAL ABNORMALITIES DETERMINE OUTCOME IN NPM1MUT/FLT3-ITDNEG/LOW ACUTE MYELOID LEUKEMIA
L. Angenendt, C. Röllig, P. Montesinos, D. Martínez-Cuadrón +41 more
2019HemaSphere0 citations Open access
Semantic Scholar
SAMHD1 HD domain bound to decitabine triphosphate
T. Oellerich, C. Schneider, D. Thomas, K. Knecht +20 more
20190 citations
Semantic Scholar
PS1403 IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE (IMCD) IN EUROPE: A HETEROGENEOUS DISEASE TREATED WITH A VARIETY OF AGENTS
C. Hoffmann, L. Terriou, P. Zinzani, A. Fossa +10 more
2019HemaSphere0 citations Open access
Semantic Scholar
Phase II Pilot Clinical Trial of Pazopanib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) or at Initial Diagnosis When No Intensive Treatment Is Possible
T. Kessler, C. Schliemann, H. Wolfgang, A. Kirsch +13 more
2018Blood0 citations
Semantic Scholar
Calcitonin Receptor-like (CALCRL) expression predicts poor survival in acute myeloid leukemia
L. Angenendt, E. Bormann, L. Braun, J. Mikesch +14 more
20170 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Schliemann×46
Invite
C. Schliemann — researcher profile on SciRah
J. Mikesch×29
Invite
J. Mikesch — researcher profile on SciRah
W. Berdel×27
Invite
W. Berdel — researcher profile on SciRah
G. Lenz×21
Invite
G. Lenz — researcher profile on SciRah

×19

Invite

T. Kessler — researcher profile on SciRah

M. Stelljes×17

Invite

M. Stelljes — researcher profile on SciRah

E. Wardelmann×14

Invite

E. Wardelmann — researcher profile on SciRah

W. Hartmann×13

Invite

W. Hartmann — researcher profile on SciRah

Invite

R. Mesters — researcher profile on SciRah

Klaus Wethmar×9

Invite

Klaus Wethmar — researcher profile on SciRah

Invite

A. Berdel — researcher profile on SciRah

C. Müller-Tidow×7

Invite

C. Müller-Tidow — researcher profile on SciRah